Agrin Moeini

Alderley Park
Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axis.

Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axis.

Journal: bioRxiv : the preprint server for biology

Published: August 06, 2025

CCR7+ activated dendritic cells are essential for spontaneous and immunotherapy-driven anti-tumor immunity.

CCR7+ activated dendritic cells are essential for spontaneous and immunotherapy-driven anti-tumor immunity.

Journal: Immunity

Published: July 02, 2025

Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis.

Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis.

Journal: Cancer discovery

Published: August 25, 2024

Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis' [J Hepatol 75 (2021) 865-878].

Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis' [J Hepatol 75 (2021) 865-878].

Journal: Journal of hepatology

Published: October 10, 2021

Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations.

Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations.

Journal: Nature communications

Published: July 16, 2021

Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy.

Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy.

Journal: Cancer discovery

Published: December 18, 2020

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.

Journal: Journal of hepatology

Published: November 30, 2020

Cell of origin in biliary tract cancers and clinical implications.

Cell of origin in biliary tract cancers and clinical implications.

Journal: JHEP reports : innovation in hepatology

Published: November 02, 2020

Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade.

Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade.

Journal: Immunity

Published: October 29, 2019

Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.

Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.

Journal: Journal of hepatology

Published: September 30, 2019

Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials.

Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials.

Journal: British journal of cancer

Published: April 15, 2019

An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.

An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.

Journal: Gastroenterology

Published: January 28, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026